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Muscular contraction is triggered by an increase in
calcium concentration, which is transmitted to the con-
tractile proteins by the troponin complex. The interac-
tions among the components of the troponin complex
(troponins T, C, and I) are essential to understanding
the regulation of muscle contraction. While the struc-
ture of TnC is well known, and a model for the binary
TnCTnI complex has been recently published (Tung,
C.-S., Wall, M. E., Gallagher, S. C., and Trewhella, J.
(2000) Protein Sci. 9, 1312–1326), very little is known
about TnT. Using non-denaturing gels and NMR spec-
troscopy, we have analyzed the interactions between
TnC and five peptides from TnT as well as how three TnI
peptides affect these interactions. Rabbit fast skeletal
muscle peptide TnT-(160–193) binds to TnC with a dis-
sociation constant of 30  6 M. This binding still occurs
in the presence of TnI-(1–40) but is prevented by the
presence of TnI-(56–115) or TnI-(96–139), both contain-
ing the primary inhibitory region of TnI. TnT-(228–260)
also binds TnC. The binding site for TnT-(160–193) is
located on the C-terminal domain of TnC and was
mapped to the surface of TnC using NMR chemical shift
mapping techniques. In the context of the model for the
TnCTnI complex, we discuss the interactions between
TnT and the other troponin subunits.
Skeletal muscle contraction is regulated by troponin and
tropomyosin located in the thin filament. Contraction begins
with the binding of Ca2 to the troponin complex, triggering
conformational changes that are propagated to tropomyosin
and actin. The troponin complex is constituted by a Ca2-
binding subunit, troponin C (TnC),1 an inhibitory subunit, tro-
ponin I (TnI), and a tropomyosin-binding subunit, troponin T
(TnT). When the muscle is relaxed, TnI inhibits myosin ATPase
activity. The smallest region of TnI capable of this inhibition is
known as the inhibitory region, or the inhibitory peptide (res-
idues 96–115). Upon binding of Ca2, TnC undergoes confor-
mational changes and removes the inhibition by TnI. TnT
binds to TnI, TnC, and tropomyosin, anchoring the troponin
complex to the thin filament and propagating the conforma-
tional changes (for reviews, see Refs. 1–3). The interactions
among the three components in the troponin complex as well as
how they are affected by the presence of calcium are essential
for understanding the regulation of muscle contraction.
The structure of skeletal TnC is well known and has been
determined by both x-ray crystallography (4–6) and nuclear
magnetic resonance (NMR) spectroscopy (7). NMR and crystal-
lographic data provided some structural information on the
interaction between TnC and fragments of TnI (8–14). A model
for the structure of the skeletal binary TnCTnI complex was
recently built based on a number of binding and activity assays
such as cross-linking, fluorescent resonance energy transfer
(FRET), and neutron scattering data as well as the available
structural information (15).
Despite the amount of information on the interactions be-
tween TnC and TnI that has emerged in the last few years, not
much is known about the structure of TnT, either isolated or
interacting with another troponin subunit. Rabbit skeletal TnT
yields two fragments when digested by chymotrypsin. The N-
terminal fragment, known as T1, binds to tropomyosin, while
the C-terminal fragment, T2, binds TnI and TnC (for reviews,
see Refs. 3 and 16). Although TnI by itself inhibits myosin
ATPase and TnC can remove the inhibition, TnT is necessary
for the Ca2-dependent regulation of myosin ATPase by the
troponin complex. Direct interaction of TnT with TnC is re-
sponsible for this calcium-sensitizing effect (17).
Herein we show that two TnT peptides, containing residues
160–193 and 228–260, bind to TnC and that other peptides in
the T2 region do not bind TnC. We also show that two TnI
peptides containing the inhibitory region compete with TnT-
(160–193) for TnC, while the first 40 residues of TnI bind to
TnC simultaneously with TnT-(160–193). Using two-dimen-
sional 1H,15N NMR spectroscopy to follow the titration of TnC
with the peptide TnT-(160–193), we calculated the binding
constant for this peptide and mapped the binding region on the
surface of TnC. We show this mapping on the model of the
binary TnCTnI complex and discuss the competition results in
this context.
MATERIALS AND METHODS
Proteins and Peptides—The expression and purification of recombi-
nant chicken skeletal TnC, NTnC, CTnC, [15N]TnC, and [13C,15N]CTnC
were performed as described previously (14, 18, 19). The rabbit fast
skeletal muscle TnI and TnT peptide analogs were synthesized by solid
phase peptide synthesis methodology and purified by reverse phase
high performance liquid chromatography, as described (20–23). TnT
residue numbers correspond to isoform TnT2f (24). The peptide se-
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RREAEK-NH2; TnI-(56 –115), acetyl-SMAEVQELCKQLHAKIDAA-
EEEKYDMEIKVQKSSKELEDMNQKLFDLRGKFKRPPLRRVR-NH2;
TnI-(96 –139), acetyl-NQKLFDLRGKFKRPPLRRVRMSADAMLKA-
LLGSKHKVCMDLRAN-NH2. Proteins and peptides were lyophilized
and resuspended in NMR buffer or non-denaturing gel electrophoresis
buffer in appropriate concentrations. All protein and peptide concen-
trations were determined by amino acid analysis in duplicate.
Gel Electrophoresis—TnC complexes with TnT and TnI peptides
were visualized on 10% glycerol-polyacrylamide gels (25). Unlabeled
recombinant TnC (or the individual domains) and the peptides were
resuspended in 20 mM Hepes pH 7.6, 100 mM NaCl, and 5 mM CaCl2.
TnT-(209–243) could not be resuspended in the buffer and was resus-
pended directly in TnC solution. Protein concentrations were deter-
mined to be 25 M for TnC, 19 M for CTnC, 16 M for NTnC, 143 M for
TnT-(151–170), 104 M for TnT-(160–193), 59 M for TnT-(181–215),
128 M for TnT-(209–243), 185 M for TnT-(228–260), 89 M for TnI-
(1–40), 103 M for TnI-(56–115), and 186 M for TnI-(96–139). TnC and
TnT or TnI peptides were mixed in ratios from 1:1 to 1:4. TnC/TnI/TnT
mixtures were made in 1:1:1 ratios. The mixtures were incubated for at
least 30 min at room temperature before analysis and then diluted in
sample buffer and analyzed in 10% glycerol, 8% polyacrylamide gels as
described (26).
TnT-(160–193) Titration of [15N]TnC—Recombinant TnC uniformly
labeled with 15N and the peptide TnT-(160–193) were resuspended in
100 mM KCl, 10 mM imidazole, 20 mM dithiothreitol, 6 mM CaCl2, 0.03%
sodium azide, and 0.2 mM 2,2-dimethyl-2-silapentane-5-sulfonic acid in
90% H2O, 10% D2O at pH 6.9. TnC concentration in the initial NMR
sample was 0.6 mM, and TnT-(160–193) concentration in the stock
solutions was 21 and 62 mM, respectively. Titration points of 0.14, 0.29,
0.43, 0.57, 0.71, 0.86, 1, 1.14, 1.29, 1.43, 1.87, and 2.3 molar equivalents
of TnT-(160–193) were observed consecutively. 2-l aliquots of the 21
mM solution were added for the first 10 points, and 2-l aliquots of the
62 mM solution were added for the last two points. Both one-dimen-
sional 1H and two-dimensional 1H,15N HSQC NMR spectra were ac-
quired at every titration point.
TnT-(160–193) Titration of [13C,15N]CTnC—Recombinant CTnC uni-
formly labeled with 15N and 13C and the peptide TnT-(160–193) were
resuspended in 100 mM KCl, 10 mM imidazole, 20 mM dithiothreitol, 6
mM CaCl2, 0.03% sodium azide, and 0.2 mM 2,2-dimethyl-2-silapentane-
5-sulfonic acid in 90% H2O, 10% D2O at pH 6.9. CTnC concentration in
the initial NMR sample was 0.9 mM, and TnT-(160–193) concentration
in the stock solution was 33 mM. Titration points of 0.15, 0.30, 0.44,
0.59, 0.74, 0.89, 1.03, 1.18, 1.33, and 1.48 molar equivalents of TnT-
(160–193) were observed consecutively. 2-l aliquots of the stock solu-
tion were added for each point. Both one-dimensional 1H and two-
dimensional 1H,15N HSQC NMR spectra were acquired at every
titration point. A last point was acquired later, with 0.54 mM CTnC and
4.69 molar equivalents of TnT-(160–193).
NMR Spectroscopy—All one-dimensional 1H and two-dimensional
1H,15N HSQC NMR spectra were acquired on a Varian Unity 600 MHz
spectrometer. One-dimensional 1H spectra were acquired using spectral
widths of 7500 or 8000 Hz, a 1H pulse width of 10 s (90o), and an
acquisition time of 2 s. The 1H,15N HSQC NMR spectra were acquired
using the sensitivity-enhanced gradient pulse sequence developed by
Lewis E. Kay and co-workers (27, 28). 1H and 15N sweep widths were
8000 and 1650 Hz, respectively. 24 transients were acquired for each
titration point. The data sets were processed using the VNMR software
package (VNMR 6.1B Varian, Palo Alto, CA) and the programs
NMRPipe (29) and NMRView (30).
RESULTS
Non-denaturing Gel Electrophoresis—The five TnT peptides
shown in Fig. 1a (TnT-(151–170), TnT-(160–193), TnT-(181–
215), TnT-(209–243), and TnT-(228–260)) were individually
mixed with TnC in the presence of Ca2 and applied to a
non-denaturing gel. TnT-(160–193) and TnT-(228–260) are
able to displace the TnC band, thus binding to TnC (Fig. 2a).
Therefore, TnT-(160–193) and TnT-(228–260) contain the
probable sites in TnT responsible for the interaction with TnC.
However, when TnT-(228–260) is mixed with TnC in TnC/TnT-
(228–260) ratios larger than 1:3, the TnC band cannot be seen
in the gel (data not shown). This probably results from the
nonspecific binding of multiple copies of TnT-(228–260) to TnC.
For this reason, this study focuses on the interactions between
TnT-(160–193) and TnC. TnT-(181–215) can be seen as a sep-
arate band in the gel in the presence or absence of TnC because
of its negative charge and does not affect the TnC band. In the
absence of Ca2 (1 mM EGTA, 10 mM MgCl2), none of the
peptides bound TnC (data not shown).
When the TnC-binding peptide TnT-(160–193) is mixed to
the individual domains of TnC in the presence of Ca2, it
causes a partial displacement of the C domain (CTnC) band
(Fig. 2b) but not of the N domain (NTnC) band. This suggests
that the interaction between TnT-(160–193) and TnC occurs
through the C domain of the protein. The weakening of the
NTnC band suggests some binding to the N domain, but no
band for the complex is seen. Given the charges of NTnC and
TnT-(160–193), a stable complex should be seen in the gel. A
weak complex would dissociate while migrating in the gel and
would not be seen as a band.
TnI peptides described in Fig. 1b (TnI-(1–40), TnI-(56–115),
and TnI-(96–169)) were combined with TnC and TnT-(160–
193) to evaluate how they would affect the interaction between
TnC and TnT-(160–193). TnT-(160–193) and the peptide con-
taining the first 40 amino acids from TnI (TnI-(1–40)) can bind
to TnC simultaneously. When either of the two peptides is
added to TnC, the TnC band is displaced. When both peptides
are added to TnC, the resulting displacement is bigger, roughly
corresponding to the sum of both individual displacements
(Fig. 2c). This displacement shows the simultaneous binding of
the two peptides to TnC. TnT-(160–193) binds to TnC with
smaller affinity than TnI-(1–40), causing only a partial dis-
placement when mixed to TnC, whereas TnI-(1–40) displaces
the band totally. When the two peptides are added simulta-
neously to TnC, some of the TnCTnI-(1–40) band is still seen
because of the weaker binding of TnT-(160–193).
FIG. 1. Schematic representation of
the peptides used in this work. a, five
TnT peptides spanning the whole T2 re-
gion; b, three TnI peptides used for com-
petition assays with the TnT peptides.
The sequence of the peptides is described
under “Materials and Methods.”
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When TnI-(96–139) is combined with TnC and TnT-(160–
193), a different result is obtained. The only displacement seen
on the TnC band is the one caused by the binding of TnI-(96–
139) (Fig. 2d), which binds to TnC with greater affinity than
TnT-(160–193) and prevents it from binding. The greater af-
finity of TnI-(96–139) can be seen from the complete displace-
ment of the TnC band that it causes, whereas TnT-(160–193)
only produces partial displacement.
The same experiment was done with TnI-(56–115) and TnT-
(160–193). As with TnI-(96–139), TnI-(56–115) also competes
with TnT-(160–193), preventing it from binding TnC (data not
shown).
Titration of [15N]TnC and [13C,15N]CTnC with TnT-(160–
193)—TnT-(160–193) was titrated into [15N]TnC and
[13C,15N]CTnC solutions. The binding was followed by two-
dimensional 1H,15N HSQC NMR spectroscopy. The two-dimen-
sional 1H,15N HSQC NMR spectra of [13C,15N]CTnC in the
beginning and the end of the titration are shown in Fig. 3 a and
b, respectively. Each cross-peak corresponds to 15N and 1H
resonances of the amide of an individual amino acid. Assign-
ments for some of the peaks are indicated in both spectra. The
two spectra are clearly different. These differences were ob-
served during the titration as a gradual shifting of the reso-
nances of the residues affected by TnT-(160–193). The binding
occurs with fast exchange kinetics on the NMR time scale. The
peaks in each titration point correspond to the weighted aver-
age of peptide-free and peptide-bound peaks. This shifting can
be seen in Fig. 4, which shows a superimposition of a region
of the two-dimensional 1H,15N HSQC NMR spectra of
[13C,15N]CTnC during the titration. While some cross-peaks
almost do not change, like those for Ala-124 and Leu-137,
others are greatly displaced in different directions, as exempli-
fied by the cross-peaks for Glu-159 and Lys-156. The peaks stop
moving when the [TnT-(160–193)]total/[CTnC]total ratio reaches
1, indicating the binding of only one TnT-(160–193) per CTnC.
Titration of whole TnC with TnT-(160–193) produced similar
results for residues in the C-terminal domain. Residues in the
N-terminal domain did not move significantly until the C-
terminal domain was saturated, and then they began to move.
Because the N domains of two TnC molecules can interact,
forming a TnC dimer (18), chemical shift changes in the N
domain can be caused by breaking of the dimer. Peak displace-
ments (the total chemical shift changes) for each residue were
calculated from the chemical shift changes of both nuclei using
Equation 1 (9).
total  15N2  1H2 (Eq. 1)
A comparison of the NMR chemical shift changes for residues
in the C domain for both titrations can be seen in Fig. 5. The
chemical shift changes for each residue were similar in both
titrations, except for the first nine residues in CTnC. This
difference is probably caused by the different environments for
this region in the two proteins. While these residues are in the
middle of the protein in TnC, in CTnC they are the N-terminal
residues.
The residues in the C domain that had a chemical shift
change greater than 100 Hz at the end of the titration were
averaged and normalized in both titrations, and the results
were plotted in the binding curves shown in Fig. 6. Five non-
overlapping cross-peaks for residues in the N domain that
moved more than 40 Hz were also averaged, normalized to the
C domain values, and plotted in Fig. 6a. The curves were fitted
to binding using Equation 2,
TnCTnT-(160–193) % TnCTnT-(160–193) (Eq. 2)
where TnC represents both [15N]TnC and [15N,13C]CTnC. The
resulting dissociation constants were 30  6 M for the C
domain of whole TnC and 38  24 M for CTnC. To calculate
the N domain binding curve, TnT-(160–193) concentrations
were adjusted at each point for the free TnT-(160–193) concen-
trations. The dissociation constant for the N domain cannot be
accurately determined because the site did not saturate during
the titration. It can be seen, however, that it is at least 10 times
bigger than for the C domain and that the binding to the N
domain is not significant until the C domain is 90% saturated.
The curve for the N domain in Fig. 6 was plotted using KD 
400 M, the minimum value that fitted the data.
Peak displacements caused by the binding of TnT-(160–193)
(shown in Fig. 5) were mapped on the protein surface both for
FIG. 2. Interaction between TnC (whole protein or individual N or C domains) and TnT and TnI peptides. TnC was combined with
one or two peptides at a time, as described under “Material and Methods,” and the mixture was analyzed by non-denaturing gel electrophoresis.
Specific combinations of peptides and/or proteins are indicated at the bottom of the gels. Gels c and d contain TnC in all lanes. a, each of the five
TnT peptides was mixed with TnC. TnT-(160–193) and TnT-(228–260) displace the TnC band and therefore bind to TnC. The TnC/peptide ratio
was 1:4 for all the peptides except TnT-(228–260). The TnC/TnT-(228–260) ratio was 1:3. b, TnT-(160–193) mixed with the individual domains of
TnC. TnT-(160–193) caused a displacement of the CTnC band but not the NTnC band. The TnC/peptide ratio was 1:4. c, TnT-(160–193) and
TnI-(1–40) bind simultaneously to TnC, causing a double displacement of the TnC band. The ratio used in this gel was 1:1:1 (TnC/TnI-(1–40)/
TnT-(160–193)). d, TnT-(160–193) and TnI-(96–139) compete for TnC. When both peptides are added to TnC the only band displacement seen is
the one caused by TnI-(96–139). The ratio in this gel was 1:1:1 (TnC/TnI-(96–139)/TnT-(160–193)).
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the C domain in the presence of TnI-(1–47) and for the whole
TnC in the model of TnCTnI (Fig. 7). The surface was colored
in a gradient according to the degree to which the residues were
affected by TnT-(160–193) binding. Regions in white corre-
spond to residues whose amide chemical shift, according to
Equation 1, did not change by more than 20 Hz during the
titration. Residues whose peaks shifted more than 120 Hz were
colored in pure red. Through this mapping, the TnT-(160–193)-
binding site on TnC can be visualized in the protein and in the
binary complex model.
DISCUSSION
Among the five peptides covering the whole T2 region in
rabbit fast skeletal muscle TnT, two peptides, containing resi-
dues 160–193 and 228–260, bind TnC according to non-dena-
turing gel electrophoresis data. These regions must therefore
contain the physiologically important TnC-binding sites in
TnT. Any binding too weak to be seen as a band in the gel under
the conditions used is not likely to be physiological. These
results are in good agreement with previous results from the
literature. Most studies showed Ca2-dependent binding to
TnC of larger peptides from the T2 region or the whole T2
containing residues 160–193 (31–34). The smallest of them
contained residues 160–210. There is also evidence of binding
for peptides containing residues 207–259, 177–231, and 240–
260 (31), although the last two peptides did not form complexes
that could be detected by electrophoresis (35). The peptide
containing residues 177–231 contains half of TnT-(160–193),
whereas 207–259 and 240–260 overlap with TnT-(228–260).
As in our experiments, these studies showed weaker binding in
the absence of Ca2, even in the presence of Mg2 (31–33).
Different studies have suggested that the C domain of TnC
adopts different conformations when bound to Ca2 or Mg2
(36, 37).
TnT-(228–260) seems to have a primary binding site on TnC
but also binds TnC nonspecifically in increased concentrations.
This nonspecific binding can affect affinity measurements and
binding site mapping. Preliminary NMR studies showed that
the peptide aggregates when in solution, and the complex
TnCTnT-(228–260) precipitates in the NMR tube (data not
shown). For these reasons, we centered this work on the char-
acteristics of TnT-(160–193) binding to TnC.
The binding site for TnT-(160–193) is located on the C-
terminal domain of TnC. Not only is TnT-(160–193) capable of
binding to CTnC, but the same residues are involved in the
binding of TnT-(160–193) to the whole protein and to CTnC,
showing that the peptide is bound to the same site in both
situations. When the C domain is saturated, TnT-(160–193)
binds to the N domain of TnC. That binding, however, occurs
with much lower affinity (more than 10 times lower) and is
likely non-physiological.
The dissociation constant for TnCTnT-(160–193) binding is
30  6 M. The affinity between TnC and TnT was previously
reported as almost 1000 times stronger (38). This difference
can be caused by different conditions or different measuring
methods, but most probably because we used a small peptide
FIG. 3. Titration of CTnC with TnT-(160–193). Contour plots of
the 600 MHz two-dimensional 1H,15N HSQC NMR spectrum of CTnC.
a, in the absence of TnT-(160–193); and b, saturated with TnT-(160–
193). Chemical shift values for 15N and 1H in each amide cross-peak
correspond to the y- and x-axis values. Assignments for some residues
are indicated.
FIG. 4. Shifting of CTnC amide NMR cross-peaks during titra-
tion with TnT-(160–193). A detail of the two-dimensional 1H,15N
HSQC NMR spectrum of CTnC in the absence of TnT-(160–193) is
shown in multiple contours, while peaks in the same region of the
spectrum after each peptide addition are shown in single contours.
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whereas the previous measurement was made using the whole
protein. The presence of residues 228–206 from TnT probably
strengthens the interaction. The difference between the affin-
ity of TnT-(160–193) for CTnC and TnC is not statistically
significant. On the other hand, the increased flexibility of the
N-terminal residues of CTnC may weaken the binding to TnC.
The CTnC titration did not have enough points to obtain a
smaller error in the curve fitting.
The binding data for the N domain in Fig. 6 has a slightly
more sigmoid shape than the expected binding curve. This
could be the result of breaking any partial dimerization of TnC.
TnC dimerizes through the N domain (18), and the observed
chemical shift changes for the N domain are the combined
effect of TnT-(160–193) binding and breaking of the dimer.
TnT-(160–193) binds to the N domain of TnC in the monomeric
state, and both reactions contribute to the binding curve.
The site was mapped on the surface of TnC in one of the two
recently published models for the TnCTnI binary complex
“model L” (15) (Fig. 7). The binding site involves hydrophobic,
negative, and positive residues, mostly between the EF hand
sites III and IV. Residues 104–107, in the beginning of site III,
form the first binding cluster. One side of both helices F and G
is also involved, and residues 156–160, close to the C-terminal
of the protein, complete the binding site for TnT-(160–193).
TnC orientation in Fig. 7 was chosen to show the binding site.
The surface not seen on the figure is mostly white and not
affected by TnT-(160–193). Chemical shift changes in the N
domain were not mapped on the protein surface because they
possibly reflect the dimerization state of TnC.
The region containing residues 160–193 in TnT involved in
TnC binding is immediately N-terminal from the TnI-binding
region. Residues 198–251 of TnT contain a hydrophobic heptad
repeat, typical of a coiled-coil structure, that has been proposed
to interact with residues 57–106 of TnI, which also contain a
hydrophobic heptad repeat (39). A TnT fragment containing
residues 177–231 of TnT bind to TnI (39), while a chicken TnT
mutant missing residues 216–263 (40) and a bovine TnT mu-
tant missing residues 203–214 (41) cannot bind TnI. These
regions correspond to residues 211–260 and 205–216 in rabbit
TnT2f, respectively. Residues 224–228 were also shown to be
critical for TnI binding (33).
Since regions of TnT responsible for TnC and TnI binding are
located side by side, it is expected that the corresponding re-
gions of TnC and TnI that interact with TnT would be closely
located in the troponin complex. In the model in Fig. 7, the
region containing the hydrophobic heptad repeat in TnI (resi-
dues 57–106) corresponds mostly to the -helix (seen in blue to
the left of the C domain of TnC), which does not interact with
TnC in the complex. It is, however, close enough to the mapped
TnT-binding site on TnC (colored in red) to suggest that these
regions could interact with consecutive regions in TnT.
The non-denaturing gel electrophoresis data (Fig. 1c) showed
that TnT-(160–193) and TnI-(1–40) can bind to TnC at the
same time. The region of TnI corresponding to TnI-(1–40) is
shown in green in Fig. 7. Even though both peptides bind to
same region of TnC, they do not interact with the same resi-
dues and would not compete for TnC binding. NMR chemical
shift changes mapping the TnI-(1–40)-binding site on CTnC
FIG. 5. Backbone amide NMR chemi-
cal shift changes in TnC (black) and
CTnC (gray) upon TnT-(160–193) bind-
ing. The total chemical shift change (total)
for each residue was calculated from Equa-
tion 1. The [TnT-(160–193)]total/[CTnC]total
ratio was equal to 1.18, and the [TnT-(160–
193)]total/[TnC]total ratio was equal to 1.14.
FIG. 6. TnT-(160–193) binding curves to TnC and CTnC, plotted from NMR chemical shift changes in the amide cross-peak in the
1H,15N HSQC NMR spectra against total TnT-(160–193)/TnC ratio. a, binding curves of TnT-(160–193) to [15N]TnC. , residues in the C
domain (KD  30.4  6.0 M); Œ, residues in the N domain (KD  400 M). The data for both curves were normalized using the maximum chemical
shift changes for the C domain. b, binding curve of TnT-(160–193) to [15N,13C]CTnC (KD  38  24 M). The error bars represent the normalized
standard deviation for each point. The dissociation constant for the C domain in both titrations was calculated by fitting the data to the binding
equation (Eq. 2) with the program xcrvfit. The dissociation constant for the N domain cannot be accurately calculated because the site did not
saturate during the experiment. An approximate curve was plotted using KD  400 M. Residues 8, 35, 64, 69, and 85 were used for the N domain
plot, while residues 101, 104, 107, 112, 118 to 121, 123, 130, 134, 139, 141, 156, 157, and 159 were used in the C domain curve fitting for [15N]TnC
titration. Residues 93, 95, 96, 101, 104, 106, 107, 112, 115, 118 to 121, 123, 130, 134, 139, 141, 156, and 159 were used in the curve fitting for
[15N,13C]CTnC.
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showed that the binding affects the residues in the hydrophobic
pocket of CTnC (14), while TnT-(160–193) affects mostly the
external surface of helices F and G in the region exposed to the
solvent.
TnI-(96–139) (Fig. 7, orange region) and TnI-(56–115) com-
pete with TnT-(160–193) binding to TnC, indicating that they
share at least part of the binding site on TnC. TnI-(96–139)
contains the inhibitory peptide (residues 96–115), shown as the
orange -hairpin to the right of TnC in Fig. 7, and an -helical
region (residues 116–139) that binds to the N domain of TnC
(9). The inhibitory peptide is the only common region between
the two peptides, and must, therefore, be the region that com-
petes with TnT-(160–193). The model for the TnCTnI binary
complex shown in Fig. 7 does not account for that competition.
We suggest that the binding site for the inhibitory peptide on
TnC overlaps the TnT-binding site, at least partially. The in-
hibitory peptide is located close to TnT in the troponin complex,
and the presence of TnT can protect the inhibitory region from
chymotryptic digestion (42). As for TnT-(160–193), TnI-(96–
115) has both electrostatic and hydrophobic interactions with
CTnC, while TnI-(1–40) has mostly hydrophobic interactions
(14). TnT-(160–193) and TnI-(96–115) may share some of the
electrostatic contacts and therefore compete for TnC.
It is interesting to observe that while TnI-(96–115) competes
with TnI-(1–40) and presumably with TnT-(160–193), TnI-(1–
40) and TnT-(160–193) do not compete. The binding site for the
inhibitory peptide probably shares different residues with TnI-
(1–40)- and TnT-(160–193)-binding sites, so that the last two
sites either do not overlap or the overlapping region is so small
that it does not significantly affect the binding.
Thus our results support much of model L from Tung et al.
(15), except for the exact position of the inhibitory peptide.
Model R is not compatible with our results. The position of TnI
residues 3–33 in model R, overlapping the mapped TnT-(160–
193)-binding site, would cause competition between TnI-(1–40)
and TnT-(160–193). We suggest that model L is probably closer
to the actual structure of the binary TnCTnI complex. This is
the first time that a TnT-binding site has been mapped on TnC.
When combined with the information available on TnI binding
to TnC, the mapping offers insights into how the three compo-
nents come together in the structure of troponin tertiary
complex.
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